SENATE FINANCE C'TEE APPROVES HEALTH BILL

10 July 1994

In a setback for US President Bill Clinton, the Senate Finance Committee has approved health reform legislation that would leave millions of Americans without insurance coverage. The proposed bill offers no universal coverage and no employer mandate.

In considering dozens of amendments, the Committee rejected a new 1% payroll tax on employers with more than 500 workers but approved conscience amendments on abortion which would allow employers to deny such coverage to workers. Also included in the vast scope of the bill is long-term care for the disabled.

At the core of the proposed legislation is a series of changes to insurance law which would make coverage more widely available, backed up by subsidies to the poor and tax breaks for some workers to encourage them to buy coverage. It would generally require insurance companies to cover everyone seeking a policy, regardless of their condition. They would also have to offer plans that meet government criteria for both physical and mental health problems though these provisions had been weakened during the Committee voting. Subsidies would be provided for those whose incomes do not exceed 200% of poverty, and tax breaks would be offered for the self-employed and workers whose employers do not pay for health coverage.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight